JoVE Logo
教师资源中心

登录

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

DOI :

10.3791/4341-v

November 13th, 2012

November 13th, 2012

13,540 Views

1Department of Radiology and Bio-X Program Canary Cancer at Stanford for Cancer Early Detection, Stanford University

Use of Cerenkov Luminescence Imaging (CLI) for monitoring preclinical cancer treatment is described here. This method takes advantage of Cerenkov Radiation (CR) and optical imaging (OI) to visualize radiolabeled probes and thus provides an alternative to PET in preclinical therapeutic monitoring and drug screening.

Tags

Cerenkov Luminescence Imaging

-- Views

Related Videos

article

Monitoring Tumor Metastases and Osteolytic Lesions with Bioluminescence and Micro CT Imaging

article

Modeling and Imaging 3-Dimensional Collective Cell Invasion

article

Protocols for Assessing Radiofrequency Interactions with Gold Nanoparticles and Biological Systems for Non-invasive Hyperthermia Cancer Therapy

article

Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue

article

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

article

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

article

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

article

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

article

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

article

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。